Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Spirometry | Research

Race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007–2012

Authors: Magnus Ekström, David Mannino

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

Spirometry reference values differ by race/ethnicity, which is controversial. We evaluated the effect of race-specific references on prevalence of lung function impairment and its relation to breathlessness and mortality in the US population.

Methods

Population-based analysis of the National Health and Nutrition Examination Survey (NHANES) 2007–2012. Race/ethnicity was analyzed as black, white, or other. Reference values for forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) were calculated for each person using the Global Lung Initiative (GLI)-2012 equations for (1) white; (2) black; and (3) other/mixed people. Outcomes were prevalence of lung function impairment (< lower limit of normal [LLN]), moderate/severe impairment (< 50%pred); exertional breathlessness; and mortality until 31 December, 2015.

Results

We studied 14,123 people (50% female). Compared to those for white, black reference values identified markedly fewer cases of lung function impairment (FEV1) both in black people (9.3% vs. 36.9%) and other non-white (1.5% vs. 9.5%); and prevalence of moderate/severe impairment was approximately halved. Outcomes by impairment differed by reference used: white (best), other/mixed (intermediate), and black (worst outcomes). Black people with FEV1 ≥ LLNblack but < LLNwhite had 48% increased rate of breathlessness and almost doubled mortality, compared to blacks ≥ LLNwhite. White references identified people with good outcomes similarly in black and white people. Findings were similar for FEV1 and FVC.

Conclusion

Compared to using a common reference (for white) across the population, race-specific spirometry references did not improve prediction of breathlessness and prognosis, and may misclassify lung function as normal despite worse outcomes in black people.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117–171. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 19902013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 385:117–171.
2.
go back to reference Bhakta NR, Kaminsky DA, Bime C, Thakur N, Hall GL, McCormack MC, Stanojevic S. Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception. Chest. 2022;161:288–97.CrossRef Bhakta NR, Kaminsky DA, Bime C, Thakur N, Hall GL, McCormack MC, Stanojevic S. Addressing Race in Pulmonary Function Testing by Aligning Intent and Evidence With Practice and Perception. Chest. 2022;161:288–97.CrossRef
3.
go back to reference Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70–88.CrossRef Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70–88.CrossRef
4.
go back to reference Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017;196:1463–72.CrossRef Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017;196:1463–72.CrossRef
5.
go back to reference Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRef Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324–43.CrossRef
6.
go back to reference Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, et al: ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022, 60. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, Cooper BG, Culver B, Derom E, Hall GL, et al: ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022, 60.
7.
go back to reference From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021. Available from: http://goldcopd.org/ [Accessed 29-07-2021]. From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021. Available from: http://goldcopd.org/ [Accessed 29-07-2021].
8.
go back to reference Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70–88.CrossRef Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200:e70–88.CrossRef
9.
go back to reference Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.CrossRef Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–68.CrossRef
10.
go back to reference Braun L. Race Correction and Spirometry: Why History Matters. Chest. 2021;159:1670–5.CrossRef Braun L. Race Correction and Spirometry: Why History Matters. Chest. 2021;159:1670–5.CrossRef
11.
go back to reference Schluger NW, Dozor AJ, Jung YEG. Rethinking the Race Adjustment in Pulmonary Function Testing. Annals of the American Thoracic Society. 2022;19:353–6.CrossRef Schluger NW, Dozor AJ, Jung YEG. Rethinking the Race Adjustment in Pulmonary Function Testing. Annals of the American Thoracic Society. 2022;19:353–6.CrossRef
12.
go back to reference Scanlon PD, Shriver MD. “Race correction” in pulmonary-function testing. N Engl J Med. 2010;363:385–6.CrossRef Scanlon PD, Shriver MD. “Race correction” in pulmonary-function testing. N Engl J Med. 2010;363:385–6.CrossRef
13.
go back to reference Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, Galanter J, Gignoux C, Hu D, Sen S, et al. Genetic Ancestry in Lung-Function Predictions. N Engl J Med. 2010;363:321–30.CrossRef Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, Galanter J, Gignoux C, Hu D, Sen S, et al. Genetic Ancestry in Lung-Function Predictions. N Engl J Med. 2010;363:321–30.CrossRef
14.
go back to reference Brehm JM, Acosta-Pérez E, Klei L, Roeder K, Barmada MM, Boutaoui N, Forno E, Cloutier MM, Datta S, Kelly R, et al. African ancestry and lung function in Puerto Rican children. J Allergy Clin Immunol. 2012;129:1484–90 e1486.CrossRef Brehm JM, Acosta-Pérez E, Klei L, Roeder K, Barmada MM, Boutaoui N, Forno E, Cloutier MM, Datta S, Kelly R, et al. African ancestry and lung function in Puerto Rican children. J Allergy Clin Immunol. 2012;129:1484–90 e1486.CrossRef
15.
go back to reference Witonsky J, Elhawary JR, Eng C, Rodríguez-Santana JR, Borrell LN, Burchard EG: Race- and Ethnicity-Based Spirometry Reference Equations: Are They Accurate for Genetically Admixed Children?Chest 2022, 162:184–195. Witonsky J, Elhawary JR, Eng C, Rodríguez-Santana JR, Borrell LN, Burchard EG: Race- and Ethnicity-Based Spirometry Reference Equations: Are They Accurate for Genetically Admixed Children?Chest 2022, 162:184–195.
16.
go back to reference Diao JA, Wu GJ, Taylor HA, Tucker JK, Powe NR, Kohane IS, Manrai AK. Clinical Implications of Removing Race From Estimates of Kidney Function. JAMA. 2021;325:184–6.CrossRef Diao JA, Wu GJ, Taylor HA, Tucker JK, Powe NR, Kohane IS, Manrai AK. Clinical Implications of Removing Race From Estimates of Kidney Function. JAMA. 2021;325:184–6.CrossRef
17.
go back to reference NHANES. 2007–2008 Procedure Manuals [https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/manuals.aspx?BeginYear=2007]. NHANES. 2007–2008 Procedure Manuals [https://​wwwn.​cdc.​gov/​nchs/​nhanes/​continuousnhanes​/​manuals.​aspx?​BeginYear=​2007].
18.
go back to reference NHANES 2009–2010 [https://wwwn.cdc.gov/nchs/nhanes/continuousnhanes/default.aspx?BeginYear=2009]. NHANES 20092010 [https://​wwwn.​cdc.​gov/​nchs/​nhanes/​continuousnhanes​/​default.​aspx?​BeginYear=​2009].
20.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–8.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–8.CrossRef
21.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRef
22.
go back to reference Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–6.CrossRef Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581–6.CrossRef
23.
go back to reference Encyclopedia of Survey Research Methods. 2008. Encyclopedia of Survey Research Methods. 2008.
24.
go back to reference The Growing Diversity of Black America [https://www.pewresearch.org/social-trends/2021/03/25/the-growing-diversity-of-black-america/]. The Growing Diversity of Black America [https://​www.​pewresearch.​org/​social-trends/​2021/​03/​25/​the-growing-diversity-of-black-america/​].
25.
go back to reference Gaffney AW, McCormick D, Woolhandler S, Christiani DC, Himmelstein DU. Prognostic implications of differences in forced vital capacity in black and white US adults: Findings from NHANES III with long-term mortality follow-up. EClinicalMedicine 2021, 39. Gaffney AW, McCormick D, Woolhandler S, Christiani DC, Himmelstein DU. Prognostic implications of differences in forced vital capacity in black and white US adults: Findings from NHANES III with long-term mortality follow-up. EClinicalMedicine 2021, 39.
26.
go back to reference Elmaleh-Sachs A, Balte P, Oelsner EC, Allen NB, Baugh A, Bertoni AG, Hankinson JL, Pankow J, Post WS, Schwartz JE, et al. Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Am J Respir Crit Care Med. 2022;205:700–10.CrossRef Elmaleh-Sachs A, Balte P, Oelsner EC, Allen NB, Baugh A, Bertoni AG, Hankinson JL, Pankow J, Post WS, Schwartz JE, et al. Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. Am J Respir Crit Care Med. 2022;205:700–10.CrossRef
27.
go back to reference Baugh AD, Shiboski S, Hansel NN, Ortega V, Barjakteravic I, Barr RG, Bowler R, Comellas AP, Cooper CB, Couper D, et al: Reconsidering the Utility of Race-Specific Lung Function Prediction Equations. Am J Respir Crit Care Med 2021. Baugh AD, Shiboski S, Hansel NN, Ortega V, Barjakteravic I, Barr RG, Bowler R, Comellas AP, Cooper CB, Couper D, et al: Reconsidering the Utility of Race-Specific Lung Function Prediction Equations. Am J Respir Crit Care Med 2021.
28.
go back to reference McCormack MC, Balasubramanian A, Matsui EC, Peng RD, Wise RA, Keet CA. Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III. Am J Respir Crit Care Med. 2022;205:723–4.CrossRef McCormack MC, Balasubramanian A, Matsui EC, Peng RD, Wise RA, Keet CA. Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III. Am J Respir Crit Care Med. 2022;205:723–4.CrossRef
29.
go back to reference Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH, Han MK. Chronic Obstructive Pulmonary Disease in America’s Black Population. Am J Respir Crit Care Med. 2019;200:423–30.CrossRef Ejike CO, Dransfield MT, Hansel NN, Putcha N, Raju S, Martinez CH, Han MK. Chronic Obstructive Pulmonary Disease in America’s Black Population. Am J Respir Crit Care Med. 2019;200:423–30.CrossRef
30.
go back to reference Lederer DJ, Arcasoy SM, Barr RG, Wilt JS, Bagiella E, D’Ovidio F, Sonett JR, Kawut SM. Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant. 2006;6:2436–42.CrossRef Lederer DJ, Arcasoy SM, Barr RG, Wilt JS, Bagiella E, D’Ovidio F, Sonett JR, Kawut SM. Racial and ethnic disparities in idiopathic pulmonary fibrosis: A UNOS/OPTN database analysis. Am J Transplant. 2006;6:2436–42.CrossRef
31.
go back to reference Townend J, Minelli C, Mortimer K, Obaseki DO, Al Ghobain M, Cherkaski H, Denguezli M, Gunesekera K, Hafizi H, Koul PA, et al: The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J 2017, 49. Townend J, Minelli C, Mortimer K, Obaseki DO, Al Ghobain M, Cherkaski H, Denguezli M, Gunesekera K, Hafizi H, Koul PA, et al: The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J 2017, 49.
32.
go back to reference Murray CJ, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ, Ezzati M. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3:e260.CrossRef Murray CJ, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, Iandiorio TJ, Ezzati M. Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med. 2006;3:e260.CrossRef
33.
go back to reference Bozzoli C, Deaton A, Quintana-Domeque C. Adult height and childhood disease. Demography. 2009;46:647–69.CrossRef Bozzoli C, Deaton A, Quintana-Domeque C. Adult height and childhood disease. Demography. 2009;46:647–69.CrossRef
34.
go back to reference Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385:1737–49.CrossRef Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385:1737–49.CrossRef
35.
go back to reference Weyand AC, McGann PT. Eliminating race-based reference ranges in haematology: a call to action. Lancet Haematol. 2021;8:e462–6.CrossRef Weyand AC, McGann PT. Eliminating race-based reference ranges in haematology: a call to action. Lancet Haematol. 2021;8:e462–6.CrossRef
Metadata
Title
Race-specific reference values and lung function impairment, breathlessness and prognosis: Analysis of NHANES 2007–2012
Authors
Magnus Ekström
David Mannino
Publication date
01-12-2022
Publisher
BioMed Central
Keyword
Spirometry
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02194-4

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.